These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 11592442

  • 1. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O, Weger M, Renner W, Konetschny R.
    Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
    [Abstract] [Full Text] [Related]

  • 2. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 3. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K, Böger RH.
    Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 5. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 6. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE.
    Arch Intern Med; 2000 Apr 10; 160(7):961-4. PubMed ID: 10761961
    [Abstract] [Full Text] [Related]

  • 7. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1997 Dec 10; 20(12):1880-6. PubMed ID: 9405911
    [Abstract] [Full Text] [Related]

  • 8. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May 10; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr 10; 240(4):286-90. PubMed ID: 11981642
    [Abstract] [Full Text] [Related]

  • 12. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD.
    J Clin Invest; 1996 Jul 01; 98(1):24-9. PubMed ID: 8690798
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
    Beaumont V, Malinow MR, Sexton G, Wilson D, Lemort N, Upson B, Beaumont JL.
    Atherosclerosis; 1992 Jun 01; 94(2-3):147-52. PubMed ID: 1632868
    [Abstract] [Full Text] [Related]

  • 15. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG.
    Clin Sci (Lond); 2001 Feb 01; 100(2):161-7. PubMed ID: 11171285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC.
    Heart Vessels; 2000 Feb 01; 15(3):135-43. PubMed ID: 11289502
    [Abstract] [Full Text] [Related]

  • 19. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.
    Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG.
    Circulation; 1999 Sep 14; 100(11):1161-8. PubMed ID: 10484535
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine as a novel risk factor for atherosclerosis.
    Guthikonda S, Haynes WG.
    Curr Opin Cardiol; 1999 Jul 14; 14(4):283-91. PubMed ID: 10448607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.